Medicalgorithmics S.A.

MDG

PLMDCLG00015

Advanced Medical Equipment & Technology

Market Closed - Warsaw S.E. Other stock markets 16:55:55 10/06/2024 BST			5-day change	1st Jan Change
26.58 ^PLN	+1.61%		+2.86%	-13.00%

05-29	Medicalgorithmics S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-22	Medicalgorithmics S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Medicalgorithmics S.A. Names Peter G. Pellerito as CEO of the US Unit Medi-Lynx

October 16, 2018 at 08:27 pm

Medicalgorithmics S.A. named Peter G. Pellerito as new CEO of the US unit Medi-Lynx.

Latest news about Medicalgorithmics S.A.

Medicalgorithmics S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-29	CI
Medicalgorithmics S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	04-22	CI
Medicalgorithmics S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023	11-29	CI
Medicalgorithmics S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	28/09/23	CI
Medicalgorithmics S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	30/05/23	CI
Medicalgorithmics S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	26/04/23	CI
Medicalgorithmics S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	29/11/22	CI
Bio Fund Management Ltd. signed an agreement to acquire 100% stake in Kardiolytics Inc. for $44.9 million.	02/10/22	CI
Medicalgorithmics S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	29/09/22	CI
Medicalgorithmics S.A. Secures FDA Approval for DeepRhytmAI Technology	10/08/22	CI
Medicalgorithmics S.A. announced a financing transaction	02/06/22	CI
Medicalgorithmics S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	30/05/22	CI
Medicalgorithmics to Consider Finding Investor for Group, Sale of Significant Assets	04/02/22	CI
Rafal Brzoska Withdrawn from Negotiations with Medicalgorithmics	21/01/22	CI
Medicalgorithmics S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/11/21	CI
Medicalgorithmics S.A. announced that it expects to receive PLN 15.58017 million in funding	14/11/21	CI
Medicalgorithmics Starts Talks with Rafal Brzoska on Acquisition of Company's Shares	26/10/21	CI
Medicalgorithmics S.A. Reports Earnings Results for the Second Quarter 2021	01/10/21	CI
Medicalgorithmics S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021	25/05/21	CI
Medicalgorithmics S.A. Reports Earnings Results for the Full Year Ended December 31, 2020	01/04/21	CI
Medicalgorithmics S.A. Reports Earnings Results for the Third Quarter Ended September 30, 2020	24/11/20	CI
Medicalgorithmics S.A. Announces Earnings Guidance for the Third Quarter of 2020	27/08/20	CI
Medicalgorithmics Reports Earnings Results for 2019	30/04/20	CI
Undisclosed buyers acquired unknown stake in Medicalgorithmics S.A..	02/03/20	CI
Medicalgorithmics healthcare Reports Earnings Results for the Third Quarter 2018	20/11/18	CI

Medicalgorithmics SA is a Poland-based company engaged in the advanced medical equipment and technology industry. The Company develops and manufactures system for the diagnosis of heart arrhythmia. Its product, named PocketECG, is used for remote monitoring of cardiac disorders, arrhythmia diagnosis and monitoring of heart, as well as is used for clinical drugs trials for cardiac safety. In addition, Medicalgorithmics SA provides services in the field of information technology and biotechnology, scientific research and development of natural sciences. Moreover, the Company works on the several projects, such as a device for tele-rehabilitation cardiology, software for optimizing repetitive task in hospitals, as well as devices and systems for remote description of the electrocardiography (ECG). It operates through MEDICALGORITHMICS US HOLDING CORPORATION and Medi-Lynx Cardiac Monitoring LLC and Medi-Lynx Cardiac Monitoring LLC.

Sector

Advanced Medical Equipment & Technology

Calendar

25/11/2024 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
MEDICALGORITHMICS S.A.	-13.00%	65.28M
SARTORIUS AG	-25.42%	16.48B
QUIDELORTHO CORPORATION	-44.21%	2.79B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+22.46%	1.94B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-12.32%	1.46B
BIOTAGE AB	+30.22%	1.33B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-16.15%	966M
REVENIO GROUP OYJ	+2.58%	791M
VAREX IMAGING CORPORATION	-23.37%	620M
CELLAVISION AB	+24.06%	577M

Medical Diagnostic & Testing Equipment